CN106473038A - A kind of Herba Cistanches health-care tablet and preparation method thereof - Google Patents
A kind of Herba Cistanches health-care tablet and preparation method thereof Download PDFInfo
- Publication number
- CN106473038A CN106473038A CN201610828744.1A CN201610828744A CN106473038A CN 106473038 A CN106473038 A CN 106473038A CN 201610828744 A CN201610828744 A CN 201610828744A CN 106473038 A CN106473038 A CN 106473038A
- Authority
- CN
- China
- Prior art keywords
- herba cistanches
- health
- preparation
- care tablet
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000005787 Cistanche Species 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 38
- 239000000284 extract Substances 0.000 claims abstract description 28
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 24
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 24
- 235000021014 blueberries Nutrition 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 19
- 229960004295 valine Drugs 0.000 claims abstract description 19
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 18
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940124277 aminobutyric acid Drugs 0.000 claims abstract description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 18
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 18
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 9
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 9
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 9
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 9
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 9
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 9
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 9
- 239000003507 refrigerant Substances 0.000 claims abstract description 9
- 229940013618 stevioside Drugs 0.000 claims abstract description 9
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019202 steviosides Nutrition 0.000 claims abstract description 9
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000007779 soft material Substances 0.000 claims abstract description 6
- 239000012467 final product Substances 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 238000000605 extraction Methods 0.000 claims description 7
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000002893 slag Substances 0.000 claims description 2
- DKXULEFCEORBJK-UHFFFAOYSA-N magnesium;octadecanoic acid Chemical compound [Mg].CCCCCCCCCCCCCCCCCC(O)=O DKXULEFCEORBJK-UHFFFAOYSA-N 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract description 16
- 235000019359 magnesium stearate Nutrition 0.000 abstract description 8
- 239000013543 active substance Substances 0.000 abstract description 2
- 230000006378 damage Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract 1
- 229960004799 tryptophan Drugs 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 8
- 244000077233 Vaccinium uliginosum Species 0.000 description 8
- 230000009182 swimming Effects 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 5
- 239000002253 acid Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 241000336291 Cistanche deserticola Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000208421 Ericaceae Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000196 olfactory nerve Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- -1 polysaccharide compound Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
A kind of preparation method of Herba Cistanches health-care tablet, it is characterized in that, raw material using following percentage by weight is made, Herba Cistanches extract 15% 22%, blue berry powder 15% 25%, aminobutyric acid 1% 5%, tryptophan 0.1% 0.8%, L-Valine 0.1% 0.8%, maltodextrin 20% 35%, Microcrystalline Cellulose 20% 35%, citric acid 0.05% 0.1%, stevioside 0.002% 0.01%, magnesium stearate 0.05% 0.2%, refrigerant alcohol 0.2% 1%, balance of water, according to the above ratio after mix homogeneously, soft material processed, cross 20 mesh sieves, dry particl is obtained after drying, tabletting obtains final product Herba Cistanches health-care tablet.The present invention, by the extract at low temperature to Herba Cistanches, obtains higher effective ingredient it is therefore prevented that the destruction to a part of active substance for the high temperature.
Description
Technical field
The present invention relates to health food manufacture field is and in particular to a kind of Herba Cistanches health-care tablet and preparation method thereof.
Background technology
Herba Cistanches (scientific name：Cistanche deserticola Ma), call boundary rue, very little rue, Herba Cistanchess, look into the sub- (illiteracy of dry announcement
Language), belong to endangered species.Tall and big draft, high 40 160 centimetres, mostly lower life.June at florescence 5, fruiting period 6 August.Main product is in new
Boundary, Alashan Area, inner Mongolia Autonomous Region alliance, Gansu, Ningxia are also distributed.
Herba Cistanches are a kind of parasitic plants colonizing in desert trees sacsaoul root, draw nutrient and water from sacsaoul host
Point.Have the good reputation of " desert Radix Ginseng ", there is high medical value, be the rare Chinese medicine of Chinese tradition.Herba Cistanches are being gone through
In history just by Western Regions various countries as Shang Gong imperial court treasure, be also usage frequency highest tonification in successive dynasties kidney invigorating and YANG supporting class prescription
One of medicine.
Herba Cistanches sweet in the mouth, warm in nature, there is the effects such as kidney invigorating and YANG supporting, benefiting essence and marrow, blood enriching and dryness moistening, happy color macrobiosis.Herba Cistanches
Medicine-food two-purpose, is eaten for a long time and can increase muscle power, stamina intensifying and resisting fatigue, can strengthen the property of the mankind and animal simultaneously again
Ability and fertility.
Blue berry, means blue berry, belongs to Ericaceae, Pericarpium Citri tangerinae platymiscium.Originate from North America, perennial shrub small berries fruit
Tree.Cause and effect is in blueness in fact, therefore referred to as blue berry.Contain abundant nutritional labeling in Blueberry, have and prevent that cranial nerve is aging, protect
The functions such as shield vision, heart tonifying, anticancer, vessel softening, enhancing human organism's immunity, nutritional labeling is high.Blueberry nutrient enriches, not only rich
Containing conventional nutrients, but also containing extremely abundant flavonoid and polysaccharide compound, be therefore otherwise known as " fruit emperor
Afterwards " and " king of berry ".Blueberry has extremely strong medical value and alimentary health-care function, and international food and agricultural organization is classified as people
One of big health food of class five.
The direct eating mouth feel of Herba Cistanches is poor, and absorbance relatively low it is impossible to its medicinal efficacy of farthest delivering, therefore
How effectively to absorb the medicinal effects of Herba Cistanches and how instant edible is researcher emphasis, the present invention is exactly from this
Purpose is set out, and have developed the excellent Herba Cistanches health-care tablet of a kind of good absorbing, mouthfeel, easy to carry.
Content of the invention
For the problems referred to above, the present invention provides a kind of Herba Cistanches health-care tablet and preparation method thereof, using the feature of Herba Cistanches
Preparation can be easy to carry health-care tablet.
The present invention solves above-mentioned technical problem and be employed technical scheme comprise that：A kind of preparation method of Herba Cistanches health-care tablet,
It is characterized in that, the raw material using following percentage by weight is made, Herba Cistanches extract 15%-22%, blue berry powder 15%-
25%th, aminobutyric acid 1%-5%, tryptophan 0.1%-0.8%, L-Valine 0.1%-0.8%, maltodextrin 20%-35%, micro-
Crystalline cellulose 20%-35%, citric acid 0.05%-0.1%, stevioside 0.002%-0.01%, magnesium stearate 0.05%-
0.2%th, refrigerant alcohol 0.2%-1%, balance of water, according to the above ratio after mix homogeneously, soft material processed, cross 20 mesh sieves, after being dried
To dry particl, tabletting obtains final product Herba Cistanches health-care tablet.
Further, described Herba Cistanches extract is pulverized for Herba Cistanches, extraction, filters, and lyophilizing obtains.
Further, described Herba Cistanches are pulverized is Herba Cistanches to be placed in Lowtemperaturepulverizer pulverize, and crosses 100 mesh sieves.
Further, described extraction is will to pulverize the powder obtaining and 5% ethanol water according to mass ratio 1：5-8 mixes,
Control 42 DEG C of extraction 3-5h of temperature.
Further, the solution after extraction is crossed 8 layers of gauze and is removed slag by described being filtered into.
A kind of Herba Cistanches health-care tablet is it is characterised in that be obtained using the method described in above-mentioned any one.
It is an advantage of the current invention that：The present invention, by the extract at low temperature to Herba Cistanches, obtains higher effective ingredient, prevents
Stop the destruction to a part of active substance for the high temperature.By adding aminobutyric acid, tryptophan, L-Valine, make effect of Herba Cistanches
It is improved.
Specific embodiment
Technical scheme will be clearly and completely described below it is clear that described embodiment is this
Bright a part of embodiment, rather than whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art are not having
There is the every other embodiment being obtained under the premise of making creative work, broadly fall into the scope of protection of the invention.
Embodiment 1：
Weigh each raw material components by following weight ratio：
Herba Cistanches extract 15%
Blue berry powder 25%
Aminobutyric acid 1.5%
Tryptophan 0.5%
L-Valine 0.5%
Maltodextrin 35%
Microcrystalline Cellulose 20%
Citric acid 0.08%
Stevioside 0.01%
Magnesium stearate 0.1%
Refrigerant alcohol 0.5%
Balance of water.
Herba Cistanches extract preparation method：Accurately weigh Herba Cistanches 100g, low-temperature grinding crosses 100 mesh sieves, by solid-liquid ratio 1:5
Add 5% ethanol water, mixing, control 42 DEG C of temperature, extract 4h, 8 layers of gauze filter off residue, and lyophilizing obtains Herba Cistanches and extracts
Thing.
By Herba Cistanches extract, blue berry powder, aminobutyric acid, tryptophan, L-Valine, maltodextrin, Microcrystalline Cellulose, Fructus Citri Limoniae
Acid, stevioside, magnesium stearate, refrigerant alcohol and water are sufficiently mixed, soft material processed, cross 20 mesh sieves, obtain dry particl, tabletting is after being dried
?.
Embodiment 2：
Weigh each raw material components by following weight ratio：
Herba Cistanches extract 22%
Blue berry powder 15%
Aminobutyric acid 1%
Tryptophan 0.2%
L-Valine 0.2%
Maltodextrin 30%
Microcrystalline Cellulose 15%
Citric acid 0.05%
Stevioside 0.008%
Magnesium stearate 0.1%
Refrigerant alcohol 0.8%
Balance of water.
Herba Cistanches extract preparation method：Accurately weigh Herba Cistanches 100g, low-temperature grinding crosses 100 mesh sieves, by solid-liquid ratio 1:8
Add 5% ethanol water, mixing, control 42 DEG C of temperature, extract 4.5h, 8 layers of gauze filter off residue, and lyophilizing obtains Herba Cistanches and carries
Take thing.
By Herba Cistanches extract, blue berry powder, aminobutyric acid, tryptophan, L-Valine, maltodextrin, Microcrystalline Cellulose, Fructus Citri Limoniae
Acid, stevioside, magnesium stearate, refrigerant alcohol and water are sufficiently mixed, soft material processed, cross 20 mesh sieves, obtain dry particl, tabletting is after being dried
?.
Embodiment 3：
Weigh each raw material components by following weight ratio：
Herba Cistanches extract 20%
Blue berry powder 20%
Aminobutyric acid 4%
Tryptophan 0.6%
L-Valine 0.6%
Maltodextrin 20%
Microcrystalline Cellulose 30%
Citric acid 0.1%
Stevioside 0.005%
Magnesium stearate 0.2%
Refrigerant alcohol 0.8%
Balance of water.
Herba Cistanches extract preparation method：Accurately weigh Herba Cistanches 100g, low-temperature grinding crosses 100 mesh sieves, by solid-liquid ratio 1:5
Add 5% ethanol water, mixing, control 42 DEG C of temperature, extract 4h, 8 layers of gauze filter off residue, and lyophilizing obtains Herba Cistanches and extracts
Thing.
By Herba Cistanches extract, blue berry powder, aminobutyric acid, tryptophan, L-Valine, maltodextrin, Microcrystalline Cellulose, Fructus Citri Limoniae
Acid, stevioside, magnesium stearate, refrigerant alcohol and water are sufficiently mixed, soft material processed, cross 20 mesh sieves, obtain dry particl, tabletting is after being dried
?.
Embodiment 4
By male mice in kunming, body weight is 20-25g, is randomly divided into 10 groups, each group 10, i.e. blank control group (distillation
Water), Herba Cistanches matched group (with Herba Cistanches extract equivalent substitution embodiment 1～3 by Herba Cistanches extract, blue berry powder, ammonia
The health-care tablet of base butanoic acid, tryptophan and L-Valine preparation), blue berry matched group is (with blue berry powder equivalent substitution embodiment 1～3
Health-care tablet by the preparation of Herba Cistanches extract, blue berry powder, aminobutyric acid, tryptophan and L-Valine), aminobutyric acid matched group (is used
Aminobutyric acid equivalent substitution reality embodiment 1～3 in by Herba Cistanches extract, blue berry powder, aminobutyric acid, tryptophan and L-Valine
Preparation health-care tablet, tryptophan group (with tryptophan equivalent substitution embodiment 1～3 by Herba Cistanches extract, blue berry
Powder, the health-care tablet of aminobutyric acid, tryptophan and L-Valine preparation), L-Valine matched group is (with L-Valine equivalent substitution embodiment 1
The health-care tablet by the preparation of Herba Cistanches extract, blue berry powder, aminobutyric acid, tryptophan and L-Valine in～3), negative control group
(formula according to embodiment 1～3 does not contain Herba Cistanches extract, blue berry powder, the sky of aminobutyric acid, tryptophan and L-Valine preparation
White tiles), the Herba Cistanches health-care tablet that embodiment 1, embodiment 2 and embodiment 3 prepare, give animal subject suspension respectively and fill
Stomach, once, gavage volume is 0.08ml/10g bw for daily filling, and continuous gavage 30 days, after last dose 30min, mice is put
In swimming trunk went swimming, swimming trunk depth of water 30cm, 28 DEG C about of water temperature, record mice swimming time, that is, mice starts from swimming
To the dead time.Result is as shown in table 1
1 10 groups of mice swimming times of table test (meansigma methodss of 10 mices)
| Group | Mice swimming time |
| Blank control group | 238 seconds |
| Negative control group | 242 seconds |
| Herba Cistanches group | 321 seconds |
| Blue berry group | 302 seconds |
| Aminobutyric acid | 287 seconds |
| Tryptophan | 275 seconds |
| L-Valine | 291 seconds |
| Embodiment 1 | 447 seconds |
| Embodiment 2 | 438 seconds |
| Embodiment 3 | 452 seconds |
Result shows, embodiment 1, embodiment 2, embodiment 3 mice swimming time are apparently higher than other matched groups.This is described
The each component of Herba Cistanches health-care tablet that invention provides has good synergistic function.
The foregoing is only presently preferred embodiments of the present invention, be not limited to the substantial technological content model of the present invention
Enclose.The substantial technological content of the present invention is broad sense in the right of application, any technology entities that other people complete or
Method, if identical with defined in the right of application, also or a kind of equivalent change, all will be considered
It is covered by among this right.
Claims (6)
1. a kind of preparation method of Herba Cistanches health-care tablet is it is characterised in that made using the raw material of following percentage by weight, meat desert
Rong extract 15%-22%, blue berry powder 15%-25%, aminobutyric acid 1%-5%, tryptophan 0.1%-0.8%, L-Valine 0.1%-0.8%,
Maltodextrin 20%-35%, Microcrystalline Cellulose 20%-35%, citric acid 0.05%-0.1%, stevioside 0.002%-0.01%, stearic acid
Magnesium 0.05%-0.2%, refrigerant alcohol 0.2%-1%, balance of water, according to the above ratio after mix homogeneously, soft material processed, cross 20 mesh sieves, be dried
After obtain dry particl, tabletting obtains final product Herba Cistanches health-care tablet.
2. a kind of preparation method of Herba Cistanches health-care tablet according to claim 1 is it is characterised in that described Herba Cistanches extract
Thing is pulverized for Herba Cistanches, extraction, filters, and lyophilizing obtains.
3. a kind of preparation method of Herba Cistanches health-care tablet according to claim 1 is it is characterised in that described Herba Cistanches are pulverized
It is Herba Cistanches to be placed in Lowtemperaturepulverizer pulverize, cross 100 mesh sieves.
4. a kind of preparation method of Herba Cistanches health-care tablet according to claim 1 is it is characterised in that described extraction is by powder
The broken powder obtaining and 5% ethanol water are according to mass ratio 1：5-8 mixes, and controls 42 DEG C of extraction 3-5h of temperature.
5. a kind of preparation method of Herba Cistanches health-care tablet according to claim 1 is it is characterised in that described being filtered into will be soaked
Solution after carrying is crossed 8 layers of gauze and is removed slag.
6. a kind of Herba Cistanches health-care tablet is it is characterised in that be obtained using the method described in Claims 1 to 5 any one.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610828744.1A CN106473038A (en) | 2016-09-18 | 2016-09-18 | A kind of Herba Cistanches health-care tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610828744.1A CN106473038A (en) | 2016-09-18 | 2016-09-18 | A kind of Herba Cistanches health-care tablet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106473038A true CN106473038A (en) | 2017-03-08 |
Family
ID=58267258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610828744.1A Pending CN106473038A (en) | 2016-09-18 | 2016-09-18 | A kind of Herba Cistanches health-care tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106473038A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107319086A (en) * | 2017-05-23 | 2017-11-07 | 天津杞源堂生物工程有限公司 | A kind of matrimony vine spun gold emperor chrysanthemum pressed candy and preparation method thereof |
| CN109486633A (en) * | 2019-01-08 | 2019-03-19 | 内蒙古坤华生物科技有限公司 | Health liquor and tablet and preparation method thereof as made from Herba Cistanches and korean pine seed |
| CN113041225A (en) * | 2021-03-26 | 2021-06-29 | 齐晓慧 | Sugar-containing Mongolian medicine powder formula granule and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104544098A (en) * | 2015-01-31 | 2015-04-29 | 张翔 | Cistanche essential tablet and preparation method thereof |
| CN104585743A (en) * | 2013-11-04 | 2015-05-06 | 呼和浩特市通瑞科技有限责任公司 | Desertliving cistanche effervescent tablet and preparation technology thereof |
| CN105919136A (en) * | 2016-05-21 | 2016-09-07 | 陕西泓逺金道生物科技有限公司 | Nutrition supplement composition with fatigue resisting and immunity improving effects and preparation and preparation method thereof |
-
2016
- 2016-09-18 CN CN201610828744.1A patent/CN106473038A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104585743A (en) * | 2013-11-04 | 2015-05-06 | 呼和浩特市通瑞科技有限责任公司 | Desertliving cistanche effervescent tablet and preparation technology thereof |
| CN104544098A (en) * | 2015-01-31 | 2015-04-29 | 张翔 | Cistanche essential tablet and preparation method thereof |
| CN105919136A (en) * | 2016-05-21 | 2016-09-07 | 陕西泓逺金道生物科技有限公司 | Nutrition supplement composition with fatigue resisting and immunity improving effects and preparation and preparation method thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107319086A (en) * | 2017-05-23 | 2017-11-07 | 天津杞源堂生物工程有限公司 | A kind of matrimony vine spun gold emperor chrysanthemum pressed candy and preparation method thereof |
| CN109486633A (en) * | 2019-01-08 | 2019-03-19 | 内蒙古坤华生物科技有限公司 | Health liquor and tablet and preparation method thereof as made from Herba Cistanches and korean pine seed |
| CN113041225A (en) * | 2021-03-26 | 2021-06-29 | 齐晓慧 | Sugar-containing Mongolian medicine powder formula granule and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100472052B1 (en) | Cosmetic composition using fermentation of natural herb medicine | |
| KR101060035B1 (en) | Herbal Compositions and Herbal Medicine Pills for Eye Fatigue and Vision Improvement | |
| CN103740566B (en) | Rosa roxbunghii medicinal liquor and preparation method thereof | |
| CN103704623B (en) | A kind of agate card fermented nutrient food | |
| CN102742840A (en) | Maca Cordyceps buccal tablet and preparation method thereof | |
| CN107586672A (en) | A kind of Rosa roxburghii health liquor and preparation method thereof | |
| CN106473038A (en) | A kind of Herba Cistanches health-care tablet and preparation method thereof | |
| CN102715313A (en) | Dandelion and Cordyceps sinensis tea | |
| KR20080019675A (en) | Oriental medicine extract and method for farming fish of the same | |
| CN103340957A (en) | Chinese herbal medicine compound for resisting fatigue of human body, nourishing kidneys and tonifying yang | |
| CN105249065B (en) | A kind of grape apple composite beverage for improving immunity | |
| CN105230860A (en) | Blending and making method of horseradish tree formula bag-brewing type medicinal tea | |
| CN110151983A (en) | A kind of Chinese materia medica preparation and preparation method thereof for tonifying Qi of the kidney | |
| CN103734345A (en) | Edible houseleek healthcare soybean milk and preparation method thereof | |
| CN104893897B (en) | A kind of preparation method of health liquor | |
| CN114681535A (en) | Machilus aquilaria sinensis and agilawood wine and making method thereof | |
| CN103798399A (en) | Soybean milk with effects of eliminating indigestion and refreshing and preparation method thereof | |
| CN113180243A (en) | Ginseng and radix puerariae paste plant composition and preparation method thereof | |
| CN106942659B (en) | Preparation method of health-care momordica charantia buccal tablets | |
| CN105029413A (en) | Maca health care composition | |
| CN112043730A (en) | Traditional Chinese medicine biological preparation for preventing and treating animal epidemic diseases | |
| CN104983021A (en) | Maca ocean health drink capable of invigorating kidney and strengthening Yang | |
| CN103589565A (en) | Compound fermentation Chinese herbal medicine health wine prepared from honeysuckle, pulp of dogwood fruit, rhizoma dioscoreae, hawthorn and lycium barbarum L. | |
| CN103461603A (en) | Food blood-nourishing tea granule for improving alimentary anemia | |
| CN106509578A (en) | Production method of instant ganoderma lucidum-poria cocos compound healthy beverage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170308 |
|
| RJ01 | Rejection of invention patent application after publication |